Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.

× No keyword cloud information.

8 in total

1. Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).

Authors: A Santoro; G Bonadonna
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333

2. [A modified MOPP regimen in the treatment of Hodgkin's disease stage III B and IV (author's transl)].

Authors: F J Tigges; E Hiller; R M Schmülling; H D Waller; K Wilms
Journal: Blut Date: 1978-08-15

3. Prognostic factors in COPP-treated patients with Hodgkin's disease.

Authors: W Gassmann; L Perenyi; N Schmitz; W Kayser; H Pralle; H Löffler
Journal: Blut Date: 1982-06

4. Adriamycin, bleomycin, vinblastine and imidazole carboxamide (ABVD) therapy for advanced Hodgkin's disease resistant to mustine, vinblastine, procarbazine and prednisolone (MVPP).

Authors: S B Sutcliffe; P F Wrigley; A G Stansfeld; J S Malpas
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333

5. Neurological toxicity of vindesine used in combination chemotherapy of 51 human solid tumors.

Authors: C Focan; R Olivier; S Le Hung; R Bays; J J Claessens; H Debruyne
Journal: Cancer Chemother Pharmacol Date: 1981 Impact factor: 3.333

6. [Results of treatment with ABVD in C-MOPP-resistant Hodgkin's disease (author's transl)].

Authors: W Gassmann; L Perenyi; H Pralle; M Graubner; N Schmitz; H Löffler
Journal: Klin Wochenschr Date: 1981-03-16

7. Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.

Authors: P J Dady; T J McElwain; D E Austin; A Barrett; M J Peckham
Journal: Br J Cancer Date: 1982-06 Impact factor: 7.640

8. Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.

Authors: P L Zinzani; S Fanti; G Battista; M Tani; P Castellucci; V Stefoni; L Alinari; M Farsad; G Musuraca; A Gabriele; E Marchi; C Nanni; R Canini; N Monetti; M Baccarani
Journal: Br J Cancer Date: 2004-08-31 Impact factor: 7.640

8 in total